All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
Introducing
Now you can personalise
your AML Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The AML Hub is an independent medical education platform, sponsored by Daiichi Sankyo, Johnson & Johnson, Kura Oncology and Syndax, and has been supported through a grant from Bristol Myers Squibb. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Bookmark this article
The American Society of Clinical Oncology (ASCO) will hold its 2017 annual meeting on June 2nd–6th at McCormick Place in Chicago, Illinois. The annual meeting brings together over 30,000 medical oncologists, hematologists and other health care professionals dealing with oncology and hematology to discuss the latest developments in research, clinical practice, and novel therapies. The deadline for submitting abstracts for presentation during the meeting is fast approaching and will close on February 7th 2017. It is also worth noting that early registration to attend the meeting and hotel reservation via the meeting site will close on 26th April 2017.
The AML Global Portal (AGP) will be attending ASCO 2017 so be sure to follow us on Twitter, Facebook, and LinkedIn, and check back both during and after the meeting for key highlights from the Oral and Educational Sessions, in addition to interviews conducted with worldwide recognized experts at the meeting.
Your opinion matters
Subscribe to get the best content related to AML delivered to your inbox